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EDITORIAL
Translational Careers
POWERED BY THE COMPUTATIONAL MUSCLE OF BIOINFORMATICS AND THE BROAD PERSPECTIVE
of systems biology, advances in biomedical science now have the capacity to transform medicine.
Yet to fully realize the health benefits of new scientific insight, we must ensure a vibrant flow of
information between the basic sciences and clinical medicine. This takes both systems and people. 
The U.S. government has made an unprecedented investment in the infrastructure required
to support a new generation of translational researchers. Through the Clinical and Translational
Science Award program (CTSA), the National Institutes of Health has created a national consor-
tium that already includes 39 centers in 23 states with an annual funding commitment of $500
million by 2012. Still in its infancy, this initiative seeks to shorten the time required to translate
research results into therapies by many means, including training researchers and providing
them with an academic home, developing tools for clinical research, streamlining regulatory
processes, and fostering interdisciplinary and interinstitutional research.
The potential is clear.
But people are the prerequisite for success. We need an array of inno-
vative investigators whose expertise spans all the disciplines of basic
discovery and medical science. As a counterpoint to federal efforts, our
private, nonprofit organizations have addressed the human capital need
in robust ways, training and funding physicians and other clinical 
scientists, and piloting models for interdisciplinary graduate training
involving biologists, physical and computational scientists and engineers,
as well as a wide range of clinical and public health professionals. 
Beyond the rigorous research education essential for all scientists,
translational scientists who will work at the boundaries of discovery and
clinical science must possess an assortment of practical and logistical
skills. They must understand the processes by which discoveries turn into
therapies, as well as the evolving role of private industry. They must navigate the regulatory
environment surrounding human-subjects research, work in teams and share the rewards of
their work, and defer financial rewards while spending years in extra training to gain this
knowledge. Existing investigators must learn new skills, but we must also attract new people
and facilitate productive interactions among them. 
The infrastructure envisioned by the CTSA initiative will provide access to resources of
enormous value. But the most precious resource for translational research is the insights of indi-
vidual investigators. All will benefit if these investigators participate in a coherent, communica-
tive community. Incompatible communications infrastructures work against this aim. We need
a means to connect people and transmit important information in a way that crosses the bound-
aries of individual subspecialties, institutions, and professional societies. Toward these ends—
and in partnership with each of our organizations, and others that wish to join us—AAAS and
Science are launching CTSciNet (http://sciencecareers.org/ctscinet), the Clinical and 
Translational Science Network. CTSciNet will combine a career-development Web portal for
clinical and translational investigators with an experimental, evolving communications infra-
structure, to be launched soon. The articles in CTSciNet will focus on educating trainees and new
investigators in translational-research skills, in the spirit of ScienceCareers, which has served sci-
entists since 1995. As it develops, CTSciNet’s online professional network will connect clinical
and translational science communities worldwide, leading to the formation of scientific relation-
ships among student peers, mentors and protégés, and collaborators in academia and industry. 
If it fulfills its potential, translational research will lead to better health for people. But trans-
lation is not one-way; the insights gained at the bedside, and from clinical and population-based
studies, will spawn hypotheses, enabling scientists to probe the mechanisms of disease in new
ways and ultimately enriching basic biology. Therefore, strengthening the support systems for
those who will accomplish this multidirectional translation can only be good for science.
– N. Andrews, J. E. Burris, T. R. Cech, B. S. Coller, W. F. Crowley Jr., E. K. Gallin, K. L. Kelner,
D. G. Kirch, A. I. Leshner, C. D. Morris, F. T. Nguyen, J. Oates, N. S. Sung
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